Calamos Wealth Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-66,323
| Closed | -$7.52M | – | 316 |
|
|
2024
Q2 | $7.52M | Buy |
66,323
+1,504
| +2% | +$171K | 0.4% | 60 |
|
|
2024
Q1 | $8.99M | Sell |
64,819
-10,999
| -15% | -$1.53M | 0.5% | 53 |
|
|
2023
Q4 | $9.41M | Sell |
75,818
-1,781
| -2% | -$221K | 0.59% | 50 |
|
|
2023
Q3 | $7.24M | Buy |
77,599
+17,082
| +28% | +$1.59M | 0.55% | 49 |
|
|
2023
Q2 | $7.78M | Sell |
60,517
-861
| -1% | -$111K | 0.57% | 47 |
|
|
2023
Q1 | $7.13M | Sell |
61,378
-1,955
| -3% | -$227K | 0.56% | 52 |
|
|
2022
Q4 | $7.17M | Buy |
63,333
+626
| +1% | +$70.9K | 0.56% | 51 |
|
|
2022
Q3 | $5.05M | Buy |
62,707
+20,119
| +47% | +$1.62M | 0.43% | 62 |
|
|
2022
Q2 | $3.17M | Sell |
42,588
-1,016
| -2% | -$75.7K | 0.28% | 81 |
|
|
2022
Q1 | $5.58M | Buy |
43,604
+568
| +1% | +$72.6K | 0.42% | 66 |
|
|
2021
Q4 | $5.78M | Sell |
43,036
-756
| -2% | -$101K | 0.42% | 61 |
|
|
2021
Q3 | $5.99M | Buy |
43,792
+484
| +1% | +$66.2K | 0.48% | 55 |
|
|
2021
Q2 | $4.62M | Sell |
43,308
-2,824
| -6% | -$301K | 0.36% | 70 |
|
|
2021
Q1 | $4.15M | Buy |
46,132
+42,552
| +1,189% | +$3.82M | 0.34% | 74 |
|
|
2020
Q4 | $331K | Buy |
+3,580
| New | +$331K | 0.03% | 241 |
|